About Mark Frohlich
Mark Frohlich is a chief executive officer and director at Indapta Therapeutics.
Mark Frohlich first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Mark Frohlich in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mark Frohlich works with at each company, as listed on that company's latest Form D.
Indapta Therapeutics Inc. · Form D, Oct 14, 2025